2025-07-15 - Analysis Report
Okay, here's an analysis of Teladoc Health Inc (TDOC), incorporating all the data you've provided.

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** TDOC
*   **Company:** Teladoc Health Inc is a telehealth company that provides virtual healthcare services.
*   **TDOC Cumulative Return:** -63.19%
*   **VOO Cumulative Return:** 96.93%
*   **Absolute Divergence:** -158.0
*   **Relative Divergence:** 0.4

**Analysis:** TDOC has significantly underperformed the S&P 500. The absolute divergence shows a considerable gap in cumulative returns. The relative divergence of 0.4 indicates that TDOC's performance is near the very bottom end of its historical underperformance range compared to VOO.

**Alpha, Beta Analysis Table:**

| Year       | CAGR     | MDD   | Alpha    | Beta  | Cap(B) |
|------------|----------|-------|----------|-------|--------|
| 2015-2017  | 76.0%    | 60.6% | 50.0%    | -0.0  | 6.1    |
| 2016-2018  | 128.0%   | 59.3% | 110.0%   | -0.0  | 8.7    |
| 2017-2019  | 176.0%   | 59.3% | 147.0%   | 0.4   | 14.7   |
| 2018-2020  | 237.0%   | 64.0% | 217.0%   | 0.1   | 35.1   |
| 2019-2021  | -83.0%   | 64.0% | -132.0%  | 0.1   | 16.1   |
| 2020-2022  | -295.0%  | 81.3% | -297.0%  | 0.0   | 4.2    |
| 2021-2023  | -488.0%  | 81.3% | -506.0%  | -0.6  | 3.8    |
| 2022-2024  | -111.0%  | 81.3% | -137.0%  | -0.8  | 1.6    |
| 2023-2025  | -34.0%   | 72.9% | -82.0%   | -0.8  | 1.4    |

**Analysis:**

*   **CAGR:**  The Compound Annual Growth Rate (CAGR) shows a dramatic shift from very high growth in earlier periods to significant losses in recent years.
*   **MDD:** The Maximum Drawdown (MDD) is consistently high, indicating substantial risk and price volatility.
*   **Alpha:** Alpha is generally very high in earlier periods but becomes significantly negative, suggesting the stock is underperforming relative to its risk (Beta).
*   **Beta:** Beta is low, fluctuating slightly around zero. This suggests that TDOC's volatility has not been strongly correlated with the overall market.
*   **Cap(B):** Market capitalization has significantly decreased during the period.

**2. Recent Price Action**

*   **Current Price:** 8.27
*   **Last Market Data:** price: 8.27, previousClose: 8.32, change: -0.6%
*   **5-Day Moving Average:** 8.63
*   **20-Day Moving Average:** 8.00
*   **60-Day Moving Average:** 7.41

**Analysis:** The price is slightly below the 5-day moving average but above the 20 and 60-day moving averages. This suggests a potential short-term downward trend. The slight decrease from the previous close indicates a small downward pressure on the stock.

**3. Market Risk Indicators and Expected Return**

*   **MRI:** 0.34 (Low Risk)
*   **RSI:** 55.08
*   **PPO:** 0.0779
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34)
*   **Recent (20-day) Relative Divergence Change:** 0.2 (+) - Short-term increase
*   **Expected Return:** -9526.6%

**Analysis:**

*   **MRI:** The Market Risk Indicator suggests a relatively low-risk environment, but it is important to note that this indicator might not fully capture the specific risks associated with TDOC.
*   **RSI:** The RSI (Relative Strength Index) is at 55.08, indicating neither overbought nor oversold conditions.
*   **PPO:** The PPO (Percentage Price Oscillator) is positive at 0.0779, suggesting a short-term upward momentum relative to a longer-term trend.
*   **Hybrid Signal:** The hybrid signal suggests a partial buy, but with caution.
*   **Delta_Previous_Relative_Divergence:** This shows a short-term improvement in relative performance compared to VOO over the past 20 days. However, consider it in the context of the overall large negative divergence.
*   **Expected Return:** The extremely negative expected return (-9526.6%) suggests that, based on current trends and historical data, an investment in TDOC is projected to significantly underperform the S&P 500 over the long term. This should be interpreted as a very strong cautionary signal.
The small change in price from the last market is unlikely to be a significant event.

**4. Recent News & Significant Events**

*   [2025-07-15] - TDOC: Major business developments, regulatory changes, or market events.
*   [2025-07-13] - TDOC: Analyst discussion of recent performance and outlook.
*   [2025-07-12] - TDOC: Stock volatility influenced by recent news, earnings reports, or executive actions.
*   [2025-07-14] - TDOC: Market experts highlight risks and opportunities.

**Analysis:** The news indicates ongoing events, potential risks, and attention from analysts and market experts, which is causing volatility.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-05-01 | -0.53 | 0.63 B$   |
| 2024-10-31 | -0.19 | 0.64 B$   |
| 2024-08-01 | -4.92 | 0.64 B$   |
| 2024-04-26 | -0.49 | 0.65 B$   |
| 2025-05-01 | -0.49 | 0.65 B$   |

**Analysis:**  The EPS (Earnings Per Share) is consistently negative, suggesting the company is not profitable. Revenue is relatively stable around $0.64-0.65 billion per quarter.

**6. Financial Information:**

Revenue and Profitability:

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-03-31 | $0.63B   | 68.73%        |
| 2024-12-31 | $0.64B   | 70.50%        |
| 2024-09-30 | $0.64B   | 71.94%        |
| 2024-06-30 | $0.64B   | 70.73%        |
| 2024-03-31 | $0.65B   | 69.89%        |

Capital and Profitability:

| Quarter    | Equity   | ROE      |
|------------|----------|----------|
| 2025-03-31 | $1.43B   | -6.52%   |
| 2024-12-31 | $1.49B   | -3.25%   |
| 2024-09-30 | $1.51B   | -2.21%   |
| 2024-06-30 | $1.50B   | -55.77%  |
| 2024-03-31 | $2.29B   | -3.58%   |

**Analysis:**

*   **Revenue and Profitability:** Revenue is stable. The profit margin remains high, indicating good cost control on services, even with losses.
*   **Capital and Profitability:** Equity has been decreasing. The negative ROE (Return on Equity) reflects the company's unprofitability and poor return on shareholder investment.

**7. Summary and Overall Analysis**

Teladoc Health Inc (TDOC) faces significant challenges.

*   **Poor Performance:**  TDOC has significantly underperformed the S&P 500.
*   **Financial Losses:**  The company is currently unprofitable, with negative EPS and ROE.
*   **High Volatility:** High MDD values suggest the stock is volatile.
*   **Decreasing Equity:** The decreasing equity value is concerning.
*   **Market Sentiment:** Recent news suggests market uncertainty and scrutiny around TDOC.
*   **Cautious Signals:** The hybrid signal and the extremely negative expected return suggest that investing in TDOC is high-risk.
* **Profit Margin**: High profit margin is a positive factor
